Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer

NCT05832892 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Interventions

DRUG: surufatinib
DRUG: KN046
DRUG: gemcitabine
DRUG: Nab paclitaxel

Sponsor

Shanghai Zhongshan Hospital

Collaborators

[object Object]